PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
about
Upconversion Nanoparticles for Bioimaging and Regenerative MedicineOrganic Nanomaterials and Their Applications in the Treatment of Oral DiseasesBioabsorbable polymers in cancer therapy: latest developmentsBiosafe nanoscale pharmaceutical adjuvant materialsPolymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypesEnabling anticancer therapeutics by nanoparticle carriers: the delivery of PaclitaxelStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketPeriadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosisA Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine ModelNanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.PLGA-loaded nanomedicines in melanoma treatment: Future prospect for efficient drug deliveryCancer nanomedicine: from targeted delivery to combination therapyControlled Drug Release from Pharmaceutical NanocarriersNovel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitroRelease retardation of model protein on polyelectrolyte-coated PLGA nano- and microparticlesA New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat ModelFe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.Doxorubicin nanobubble for combining ultrasonography and targeted chemotherapy of rabbit with VX2 liver tumor.HematoPorphyrin Monomethyl Ether polymer contrast agent for ultrasound/photoacoustic dual-modality imaging-guided synergistic high intensity focused ultrasound (HIFU) therapy.Delivery of cancer therapeutics using nanotechnologySuperparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells.Self-Assembled Bifunctional Peptide as Effective Drug Delivery Vector with Powerful Antitumor Activity.Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation.Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview.Chemical glycosylation of cytochrome c improves physical and chemical protein stability.2011 Rita Schaffer lecture: nanoparticles for intracellular nucleic acid delivery.Effects of block copolymer properties on nanocarrier protection from in vivo clearance.Chemopreventive efficacy of naringenin-loaded nanoparticles in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis.Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.Synthesis and characterization of a poly(lactic-co-glycolic acid) core + poly(N-isopropylacrylamide) shell nanoparticle systemPoly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration.Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.Development and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker.PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients.Engineering cells with intracellular agent-loaded microparticles to control cell phenotype.Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles.
P2860
Q26744465-E694DEAD-A98B-4CE1-A5FA-1D18119E3271Q26766613-510BA186-0AEB-4C3A-A9B2-8B594A75CFE9Q26775714-787630F0-10E9-4715-AB49-2D5726C4B1DAQ26829798-1A3BA996-EFF8-44A1-867E-1178E5981B51Q26830537-4D1C797A-1A01-4B8F-B671-9D09AC961BA1Q26999288-40DF20D5-E4D5-4F75-995D-29CA66D72536Q27015050-20A73AE4-BE65-4F6C-86CA-F2147184E06FQ27321271-63DC87B4-CF0C-4549-B4B1-651BE96A7206Q27323374-66C9E7EA-AAB0-46E1-82E2-7F540D1D57D0Q27350484-857A604A-066A-42C7-A15F-812479C8F602Q28076905-8B0FC628-4143-4F00-B608-0823632D8C2FQ28083065-7C2BBAC5-3F4D-4D04-9D68-E1241A4C9744Q28257050-ECFDF9BB-8F33-4125-AE41-D126752976A5Q28476756-AA00DF83-C3BE-4AE2-8C2B-18088DEE4ABEQ28541146-94DBF698-7989-4746-A387-649C5B8E10D7Q28546468-77CF2BB0-F2B4-4811-8951-52CA26539909Q30362955-051A6E01-94B7-4D80-A16B-EDF077930D1EQ30375538-D198B1A1-54F7-440A-82F5-CF7C8D943CA7Q30375695-3D492399-2E4F-4587-8ABC-6207ECDE4163Q30446963-6BC93BEE-742D-42F4-B7F9-672B9AD24622Q30465367-6B81203D-6C78-4F6C-BDFE-89E82226AF59Q30924999-59473FD0-8C8A-4E29-9ECE-233EEDE556CFQ33577737-BDC14225-910F-4920-AF8B-522B68278471Q33599486-ED40211A-BCFA-4769-AAF9-555D7F691661Q33694279-CDAC4B07-7A26-4FC5-9BD3-AE767F448C38Q34062756-E306D003-23EF-4CDB-9E03-5C01F6621EB1Q34208751-4D3BB6A0-F41A-40E9-B468-FA110CF615D9Q34283992-432C2BC5-E9BD-4706-8E9A-3006AAE9B821Q34509239-482F6F06-CA1E-47E4-8888-CD315B458422Q34532926-F944D6EA-A0F7-4F61-B638-651CE99FB41BQ34626900-903C2EDA-1433-45C0-B58B-F5A894F857F0Q34630736-5D3131CF-20CA-4C4D-8819-1119E0633604Q34637830-58BD4664-A9E2-4BCC-8EFF-6D28900908B7Q34678948-B544182B-42E8-4E96-A8F4-95BC4EA477DDQ34733497-F4F477AA-85E2-4A0D-A742-62A3C1E8E648Q34756512-F4D70D12-18D6-4C07-BAF8-A67A4DCD9E4FQ34982384-A36D8081-19AD-4369-ACE5-3202ABA5EF03Q35007929-C41AE743-8F1D-442E-A2E9-25543606B78AQ35060703-009B1049-5C66-44FB-AFB7-E201BB09CE1DQ35119565-97AFFEA3-5BB7-4BA1-8267-52AA03110B68
P2860
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PLGA nanoparticles containing ...... tumour delivery by EPR effect.
@en
PLGA nanoparticles containing ...... tumour delivery by EPR effect.
@nl
type
label
PLGA nanoparticles containing ...... tumour delivery by EPR effect.
@en
PLGA nanoparticles containing ...... tumour delivery by EPR effect.
@nl
prefLabel
PLGA nanoparticles containing ...... tumour delivery by EPR effect.
@en
PLGA nanoparticles containing ...... tumour delivery by EPR effect.
@nl
P1476
PLGA nanoparticles containing ...... tumour delivery by EPR effect.
@en
P2093
Sanjeeb K Sahoo
Sarbari Acharya
P304
P356
10.1016/J.ADDR.2010.10.008
P407
P577
2010-10-20T00:00:00Z